USD 11.21
(-1.23%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 49.55 Million | -133.83 Million | 5.91 Million | 24.55 Million | 22.4 Million | 20.61 Million |
Net Income | -21.15 Million | -63.13 Million | 93.59 Million | -23.71 Million | 28.53 Million | 22.33 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -181.29 Thousand | -1.75 Million | -745.03 Thousand | 1.07 Million | 243.14 Thousand | 556.06 Thousand |
Other non-cash items | 70.89 Million | -68.94 Million | -86.93 Million | 47.19 Million | -6.37 Million | -2.27 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -51.15 Million | 134.66 Million | -5.61 Million | -24.99 Million | -22.11 Million | -20.61 Million |
Debt repayment | - | - | -2.57 Million | -3.72 Million | -1.54 Million | -1.67 Million |
Dividends payments | -28.63 Million | -26.73 Million | -22.44 Million | -22.56 Million | -23.36 Million | -23.26 Million |
Common Stock Repurchased | - | - | -2.5 Million | - | - | - |
Common Stock Issuance | 2.61 Million | 13.45 Million | 17.21 Million | - | - | - |
Other Financing Activities | -25.12 Million | 147.94 Million | 2.12 Million | 1.29 Million | 2.79 Million | 4.32 Million |
Accounts receivables | 229.97 Thousand | 16.45 Million | -120.46 Thousand | 1.01 Million | 55.34 Thousand | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | -411.27 Thousand | -18.2 Million | -624.56 Thousand | 57.58 Thousand | 187.8 Thousand | - |
Cash at beginning of period | 1.59 Million | 298.56 Thousand | - | 444.38 Thousand | 154.95 Thousand | - |
Cash at end of period | - | 1.12 Million | 298.56 Thousand | - | 444.38 Thousand | - |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.59 Million | 827.43 Thousand | 298.56 Thousand | -444.38 Thousand | 289.43 Thousand | - |
Free Cash Flow | 49.55 Million | 37.73 Million | 5.91 Million | 24.55 Million | 22.4 Million | 20.61 Million |
Breakdown | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -4.19 Million | -21.15 Million | -4.19 Million | -6.38 Million | -6.38 Million | 9.49 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 225.03 Thousand | -181.29 Thousand | 225.03 Thousand | -110.05 Thousand | -110.05 Thousand | 4.74 Million |
Other non-cash items | 15.1 Million | 70.89 Million | 15.1 Million | 20.13 Million | 20.13 Million | -4.81 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | -12.41 Million | -51.15 Million | -12.41 Million | -13.16 Million | -13.16 Million | -8.96 Million |
Debt repayment | - | - | - | - | - | -4790.00 |
Dividends payments | -5.63 Million | -28.63 Million | -5.63 Million | -8.68 Million | -8.68 Million | -5.14 Million |
Common Stock Repurchased | - | - | - | - | - | -10.64 Thousand |
Common Stock Issuance | - | 2.61 Million | - | - | - | 1.84 Million |
Other Financing Activities | -6.78 Million | -25.12 Million | -6.78 Million | -4.47 Million | -4.47 Million | -5.64 Million |
Accounts receivables | 225.03 Thousand | 229.97 Thousand | 225.03 Thousand | -110.05 Thousand | -110.05 Thousand | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | -411.27 Thousand | - | - | - | - |
Cash at beginning of period | - | 1.59 Million | - | - | - | 1.12 Million |
Cash at end of period | -1.27 Million | - | -1.27 Million | 479.69 Thousand | 479.69 Thousand | 1.59 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.27 Million | -1.59 Million | -1.27 Million | 479.69 Thousand | 479.69 Thousand | 471 Thousand |
Free Cash Flow | 11.13 Million | 49.55 Million | 11.13 Million | 13.64 Million | 13.64 Million | 9.43 Million |
AARTIDRUGS
SGLLV
IAUX
FSL
4502
BRTHF